The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy

被引:17
作者
Verdoodt, B [1 ]
Blazek, T [1 ]
Rauch, P [1 ]
Schuler, G [1 ]
Steinkasserer, A [1 ]
Lutz, MB [1 ]
Funk, JO [1 ]
机构
[1] Univ Erlangen Nurnberg, Dept Dermatol, D-91052 Erlangen, Germany
关键词
anergy; T lymphocytes; superantigens; cell cycle;
D O I
10.1002/eji.200323960
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent evidence suggests that the cyclin-dependent kinase (Cdk) inhibitors p27(Kip1) and P21(Cip1) are important factors in T cell anergy, but it has remained unclear whether anergy can be induced in their absence. We therefore induced anergy by stimulation of purified T cells from wild-type, p21(Cip1-/-), and p27(Kip1-/-) mice with anti-CD3 antibodies. Anergic wild-type T cells were arrested in the G1 phase of the cell cycle with a high p27(Kip1) protein level and low Cdk2 activity. In p27(-/-) and p21(-/-) T cells, the pattern of protein expression was preserved, but Cdk2 activity was increased. To confirm the in vivo relevance of these data, anergy was induced by repeated injection of mice with staphylococcal enterotoxin B (SEB), which leads to partial deletion of the responsive Vbeta(8+) T cell population and anergy in the remaining T cells. p21(-/-) mice and wild-type mice reacted similarly to this treatment. p27(-/-) mice showed reduced deletion of SEB-responsive T cells, but persisting T cells were anergic. These data indicate that other cell cycle regulators contribute to the cell cycle arrest of anergic T cells, as neither Cdk inhibitor is required for the induction of anergy.
引用
收藏
页码:3154 / 3163
页数:10
相关论文
共 49 条
[1]  
AJCHENBAUM F, 1993, J BIOL CHEM, V268, P4113
[2]   The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development [J].
Balomenos, D ;
Martín-Caballero, J ;
García, MI ;
Prieto, I ;
Flores, JM ;
Serrano, M ;
Martínez, C .
NATURE MEDICINE, 2000, 6 (02) :171-176
[3]   Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo [J].
Belfrage, H ;
Dohlsten, M ;
Hedlund, G ;
Kalland, T .
IMMUNOLOGY, 1997, 90 (02) :183-188
[4]   Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment [J].
Belfrage, H ;
Dohlsten, M ;
Hedlund, G ;
Kalland, T .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 44 (02) :77-82
[5]  
Boonen GJJC, 1999, EUR J IMMUNOL, V29, P789
[6]   p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes [J].
Boussiotis, VA ;
Freeman, GJ ;
Taylor, PA ;
Berezovskaya, A ;
Grass, I ;
Blazar, BR ;
Nadler, LM .
NATURE MEDICINE, 2000, 6 (03) :290-297
[7]   RADIATION-INDUCED CELL-CYCLE ARREST COMPROMISED BY P21 DEFICIENCY [J].
BRUGAROLAS, J ;
CHANDRASEKARAN, C ;
GORDON, JI ;
BEACH, D ;
JACKS, T ;
HANNON, GJ .
NATURE, 1995, 377 (6549) :552-557
[8]   Transferable anergy: Superantigen treatment induces CD4(+) T cell tolerance that is reversible and requires CD4(-)CD8(-) cells and interferon gamma [J].
Cauley, LS ;
Cauley, KA ;
Shub, F ;
Huston, G ;
Swain, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :71-81
[9]   Immobilized anti-CD3 mAb induces anergy in murine naive and memory CD4(+) T cells in vitro [J].
Chai, JG ;
Lechler, RI .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (07) :935-944
[10]  
Chen D, 1999, J IMMUNOL, V163, P5796